-
Catalog
C000878
-
Alternative name
Plasminogen activator inhibitor 2 CLIA KIT; Monocyte Arg-serpin CLIA KIT; Placental plasminogen activator inhibitor CLIA KIT; Serpin B2 CLIA KIT; Urokinase inhibitorSERPINB2 CLIA KIT; PAI2 CLIA KIT; PLANH2 CLIA KIT; PAI-2 CLIA KIT
-
GenePAI2
-
Species ReactivityHuman
-
SpecificityThis assay has high sensitivity and excellent specificity for detection of Plasminogen Activator Inhibitor 2 (PAI2).
No significant cross-reactivity or interference between Plasminogen Activator Inhibitor 2 (PAI2) and analogues was observed.
-
SamplesPlasma
-
Detection Range0.14-100ng/mL
-
SensitivityThe minimum detectable dose of this kit is typically less than 0.07ng/mL.
-
PrecisionIntra-assay Precision (Precision within an assay): 3 samples with low, middle and high level Plasminogen Activator Inhibitor 2 (PAI2) were tested 20 times on one plate, respectively.
Inter-assay Precision (Precision between assays): 3 samples with low, middle and high level Plasminogen Activator Inhibitor 2 (PAI2) were tested on 3 different plates, 8 replicates in each plate.
CV(%) = SD/meanX100
Intra-Assay: CV<10%
Inter-Assay: CV<12%
-
Product Description specificalPrinciple of the Assay: The microtiter plate provided in this kit has been pre-coated with an antigen. Standards or samples are then added to the appropriate microtiter plate wells with a biotin-conjugated secondary antibody. Next, Avidin conjugated to Horseradish Peroxidase (HRP) is added to each microplate well and incubated. Then the mixture of substrate A and B is added to generate glow light emission kinetics. Upon plate development, the intensity of the emitted light is proportional to the Plasminogen Activator Inhibitor 2 (PAI2) level in the sample or standard.
-